NYC Health + Hospitals/Bellevue today announced that its Pediatric Primary Care Clinic has received the “HPV Vaccine Is Cancer Prevention Champion Award” for outstanding efforts to protect adolescents from cancers caused by the human papillomavirus (HPV) and achieving high HPV vaccination rates. The national award is a partnership of the Centers for Disease Control and Prevention, the Association of American Cancer Institutes, and the American Cancer Society. The hospitals’ efforts to reduce the burden of cancer reflects the public health system’s broader multi-year redesign to build a competitive, sustainable organization that will continue to offer high-quality and accessible health care to the people of New York City.
“We are proud to be leader in the fight against cancer by expanding access to HPV vaccination among adolescents,” said William Hicks, CEO, NYC Health+ Hospitals/Bellevue. “Thanks to our innovative approaches to educate patients, we have been able to achieve an 86 percent HPV vaccination rate.”
“Our Pediatric Primary Care Clinic is an early adopter of the HPV vaccine. More than three years ago, we adopted the strategy of promoting the initiation of HPV vaccination at nine years of age, which is a key factor in achieving high rates of immunization. We engage and educate our patients about the importance of the HPV vaccine as cancer prevention and as one of the vaccines in a series of routine child and adolescent vaccines.” said Dr. Arthur Fierman, NYC Health + Hospitals/Bellevue Pediatric Clinic Chief, Co-Chair of the NYC Health + Hospitals Pediatric Council and Co-Chair of the NYC Childhood Immunization Coalition and CDC Childhood Immunization Champion in 2013.
“I commend Bellevue for expanding their HPV vaccine education and leading the way in the fight against cancer. This is another testament to the commitment of Bellevue and the public health system to provide innovative and high quality health care to New Yorkers. It is another one of the many reasons to make sure we continue supporting our public health system,” said Assembly Member Harvey Epstein.
“A hearty congratulations to NYC Health + Hospitals/Bellevue for their commitment to innovation and cancer prevention. I am glad New Yorkers and my constituents can benefit from an institution that is on the cutting-edge of vaccinations,” said NYC Council Member Keith Powers.
HPV vaccine protects against cancers caused by human papillomavirus infection. HPV is a very common virus; nearly 80 million people are currently infected in the United States. Every year in the United States, 33,700 women and men are diagnosed with a cancer caused by HPV infection. HPV vaccination could prevent more than 90 percent of these cancers—about 31,000—from occurring. Both boys and girls should start the HPV vaccine series when they are 11 or 12 years old—or earlier—and finish all recommended doses before they turn age 13.The HPV vaccine series can be started as early as age 9.
Every year, the award honors up to one champion from all 50 U.S. states, eight U.S. Territories and Freely Associated States, and the District of Columbia. Immunization programs submit nominations for the HPV Vaccine is Cancer Prevention Champion in their state or territory. Nominees must be a clinician, clinic, practice, group, or health system that treats adolescents as part of their overall patient population and must have an HPV vaccine series completion rate at 60 percent or higher for their adolescent patient population.
In receiving this award, NYC Health + Hospitals/Bellevue succeeds NYC Health + Hospitals/Jacobi, the region’s previous winner—demonstrating the ongoing commitment and leadership of the nation’s largest public health system to HPV vaccination and cancer prevention.
To read NYC Health + Hospitals/Bellevue’s profile on the CDC’s website and to learn more about HPV Vaccine Is Cancer Prevention Champion Award program, please visit https://www.cdc.gov/hpv.
Contact:Melissa Henry, NYC Health + Hospitals/Bellevue, 212-562-4516
About NYC Health + Hospitals/Bellevue
NYC Health + Hospitals/Bellevue is America’s oldest public hospital, established in 1736. Affiliated with the NYU School of Medicine, the 844-bed hospital is a major referral center for highly complex cases, with its 6,000 employees including highly skilled, interdisciplinary clinical staff. It sees more than 110,000 emergency room visits and 500,000 outpatient visits annually. Clinical centers of excellence include: Emergency Medicine and Trauma Care; Cardiovascular Services; Designated Regional Perinatal Center and Neonatal Intensive Care Unit (ICU); Comprehensive Children’s Psychiatric Emergency Program; and Cancer Services. For more information, visit www.nychealthandhospitals.org/bellevue or find us on twitter.com/BellevueHosp.
About NYC Health + Hospitals
NYC Health + Hospitals is the largest public health care system in the nation serving more than a million New Yorkers annually in more than 70 patient care locations across the city’s five boroughs. A robust network of outpatient, neighborhood-based primary and specialty care centers anchors care coordination with the system’s trauma centers, nursing homes, post-acute care centers, home care agency, and MetroPlus health plan—all supported by 11 essential hospitals. Its diverse workforce of more than 42,000 employees is uniquely focused on empowering New Yorkers, without exception, to live the healthiest life possible. For more information, visit www.nychealthandhospitals.org and stay connected on Facebook at https://www.facebook.com/NYCHealthSystem or Twitter at @NYCHealthSystem.